Cited by 131Epigenetics and DNA MethylationAlzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cross-region reduction in 5-hydroxymethylcytosine in Alzheimer's disease brain

Open access
Condliffe, Daniel, Wong, Andrew, Troakes, Claire, Proitsi, Petroula, Patel, Yogen, Chouliaras, Leonidas, Fernandes, Cathy, Cooper, Jonathan +4 more·2014·Neurobiology of Aging

Abstract

Epigenetic processes play a key role in the central nervous system and altered levels of 5-methylcytosine have been associated with a number of neurologic phenotypes, including Alzheimer's disease (AD). Recently, 3 additional cytosine modifications have been identified (5-hydroxymethylcytosine, 5-formylcytosine, and 5-carboxylcytosine), which are thought to be intermediate steps in the demethylation of 5-methylcytosine to unmodified cytosine. Little is known about the frequency of these modifications in the human brain during health or disease. In this study, we used immunofluorescence to confirm the presence of each modification in human brain and investigate their cross-tissue abundance in AD patients and elderly control samples. We identify a significant AD-associated decrease in global 5-hydroxymethylcytosine in entorhinal cortex and cerebellum, and differences in 5-formylcytosine levels between brain regions. Our study further implicates a role for epigenetic alterations in AD.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.neurobiolaging.2014.02.002

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Age-dependent DNA methylation that occur in the brain are associated with the risk of developing various neurological diseases, including AD.

    “Age-dependent DNA methylation that occur in the brain are associated with the risk of developing various neurological diseases14, including AD15,16.”

    From Integrated analysis of behavioral, epigenetic, and gut microbiome analyses in AppNL-G-F, AppNL-F, and wild type mice (2021) · cites this paper as [16]

    The Introduction says some hydroxymethylated CpG sites change with aging, and the Conclusions report reduced 5-hydroxymethylcytosine in AD brain. The paper does not establish that age-dependent methylation changes are associated with the risk of developing AD; it compares brain tissue from AD cases and elderly controls. (LLM, conf=0.86)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 31 · Cited by 131

Research works printed but not linked: 26

  1. Bakulski KM Dolinoy DC Sartor MA Paulson HL Konen JR Lieberman AP Albin RL Hu H Rozek LS 2012 Genome-wide DNA methylation differences between late-onset Alzheimer’s disease and cognitively normal controls in human frontal cortex Journal of Alzheimer’s disease: JAD 29 3 571 88 PMC3652332 22451312
  2. Booth MJ Branco MR Ficz G Oxley D Krueger F Reik W Balasubramanian S 2012 Quantitative sequencing of 5-methylcytosine and 5-hydroxymethylcytosine at single-base resolution Science 336 6083 934 7 22539555
  3. Booth MJ Ost TW Beraldi D Bell NM Branco MR Reik W Balasubramanian S 2013 Oxidative bisulfite sequencing of 5-methylcytosine and 5-hydroxymethylcytosine Nature protocols 8 10 1841 51 PMC3919000 24008380
  4. Chouliaras L Mastroeni D Delvaux E Grover A Kenis G Hof PR Steinbusch HW Coleman PD Rutten BP van den Hove DL 2013 Consistent decrease in global DNA methylation and hydroxymethylation in the hippocampus of Alzheimer’s disease patients Neurobiology of aging 34 9 2091 9 23582657 PMC3955118
  5. Davies MN Volta M Pidsley R Lunnon K Dixit A Lovestone S Coarfa C Harris RA Milosavljevic A Troakes C Al-Sarraj S Dobson R Schalkwyk LC Mill J 2012 Functional annotation of the human brain methylome identifies tissue-specific epigenetic variation across brain and blood Genome biology 13 6 R43 22703893 PMC3446315
  6. Gatz M Reynolds CA Fratiglioni L Johansson B Mortimer JA Berg S Fiske A Pedersen NL 2006 Role of genes and environments for explaining Alzheimer disease Archives of general psychiatry 63 2 168 74 16461860
  7. Globisch D Munzel M Muller M Michalakis S Wagner M Koch S Bruckl T Biel M Carell T 2010 Tissue distribution of 5-hydroxymethylcytosine and search for active demethylation intermediates PloS one 5 12 e15367 21203455 PMC3009720
  8. Hashimoto H Liu Y Upadhyay AK Chang Y Howerton SB Vertino PM Zhang X Cheng X 2012 Recognition and potential mechanisms for replication and erasure of cytosine hydroxymethylation Nucleic acids research 40 11 4841 9 22362737 PMC3367191
  9. Inoue A Shen L Dai Q He C Zhang Y 2011 Generation and replication-dependent dilution of 5fC and 5caC during mouse preimplantation development Cell research 21 12 1670 6 22124233 PMC3357997
  10. Jin SG Kadam S Pfeifer GP 2010 Examination of the specificity of DNA methylation profiling techniques towards 5-methylcytosine and 5-hydroxymethylcytosine Nucleic acids research 38 11 e125 20371518 PMC2887978
  11. Jin SG Wu X Li AX Pfeifer GP 2011 Genomic mapping of 5-hydroxymethylcytosine in the human brain Nucleic acids research 39 12 5015 24 21378125 PMC3130285
  12. Khare T Pai S Koncevicius K Pal M Kriukiene E Liutkeviciute Z Irimia M Jia P Ptak C Xia M Tice R Tochigi M Morera S Nazarians A Belsham D Wong AH Blencowe BJ Wang SC Kapranov P Kustra R Labrie V Klimasauskas S Petronis A 2012 5-hmC in the brain is abundant in synaptic genes and shows differences at the exon-intron boundary Nature structural & molecular biology 19 10 1037 43 PMC3465469 22961382
  13. Li W Liu M 2011 Distribution of 5-hydroxymethylcytosine in different human tissues Journal of nucleic acids 2011 870726 21772996 PMC3136188
  14. Lunnon K Mill J 2013 Epigenetic studies in Alzheimer’s disease: current findings, caveats and considerations for future studies American journal of medical genetics Part B, Neuropsychiatric genetics: the official publication of the International Society of Psychiatric Genetics In Press PMC3947441 24038819
  15. Mastroeni D Grover A Delvaux E Whiteside C Coleman PD Rogers J 2010 Epigenetic changes in Alzheimer’s disease: decrements in DNA methylation Neurobiology of aging 31 12 2025 37 19117641 PMC2962691
  16. Mastroeni D McKee A Grover A Rogers J Coleman PD 2009 Epigenetic differences in cortical neurons from a pair of monozygotic twins discordant for Alzheimer’s disease PloS one 4 8 e6617 19672297 PMC2719870
  17. Nestor C Ruzov A Meehan R Dunican D 2010 Enzymatic approaches and bisulfite sequencing cannot distinguish between 5-methylcytosine and 5-hydroxymethylcytosine in DNA BioTechniques 48 4 317 9 20569209
  18. Pidsley R Mill J 2011 Epigenetic studies of psychosis: current findings, methodological approaches, and implications for postmortem research Biological psychiatry 69 2 146 56 20510393
  19. Raiber EA Beraldi D Ficz G Burgess H Branco MR Murat P Oxley D Booth MJ Reik W Balasubramanian S 2012 Genome-wide distribution of 5-formylcytosine in ES cells is associated with transcription and depends on thymine DNA glycosylase Genome biology 13 8 R69 22902005 PMC3491369
  20. Rao JS Keleshian VL Klein S Rapoport SI 2012 Epigenetic modifications in frontal cortex from Alzheimer’s disease and bipolar disorder patients Translational psychiatry 2 e132 22760556 PMC3410632
  21. Song CX Szulwach KE Dai Q Fu Y Mao SQ Lin L Street C Li Y Poidevin M Wu H Gao J Liu P Li L Xu GL Jin P He C 2013 Genome-wide profiling of 5-formylcytosine reveals its roles in epigenetic priming Cell 153 3 678 91 23602153 PMC3657391
  22. Song CX Yi C He C 2012 Mapping recently identified nucleotide variants in the genome and transcriptome Nature biotechnology 30 11 1107 16 PMC3537840 23138310
  23. Stroud H Feng S Morey Kinney S Pradhan S Jacobsen SE 2011 5-Hydroxymethylcytosine is associated with enhancers and gene bodies in human embryonic stem cells Genome biology 12 6 R54 21689397 PMC3218842
  24. Szulwach KE Li X Li Y Song CX Wu H Dai Q Irier H Upadhyay AK Gearing M Levey AI Vasanthakumar A Godley LA Chang Q Cheng X He C Jin P 2011 5-hmC-mediated epigenetic dynamics during postnatal neurodevelopment and aging Nature neuroscience 14 12 1607 16 PMC3292193 22037496
  25. Tahiliani M Koh KP Shen Y Pastor WA Bandukwala H Brudno Y Agarwal S Iyer LM Liu DR Aravind L Rao A 2009 Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1 Science 324 5929 930 5 19372391 PMC2715015
  26. Thies W Bleiler L 2011 2011 Alzheimer’s disease facts and figures Alzheimer’s & dementia: the journal of the Alzheimer’s Association 7 2 208 44 21414557

Authors
Condliffe, D., Wong, A., Troakes, C., Proitsi, P., Patel, Y., Chouliaras, L., Fernandes, C., Cooper, J., Lovestone, S., Schalkwyk, L., Mill, J., & Lunnon, K.
Affiliations
  • King's College London (GB)
  • Maastricht University Medical Centre (NL)
  • University of Exeter (GB)
Corresponding author
Lunnon, Katie
Venue
Neurobiology of Aging
Publisher
Elsevier BV
Published
2014-08
Volume
35
Issue
8
Pages
1850-1854
ISSN
0197-4580 (ISSN-L)
OpenAlex
W2126837205
Cited by
131
References
31
Citations by year
2026: 4 · 2025: 4 · 2024: 11 · 2023: 7 · 2022: 3 · 2021: 11 · 2020: 11 · 2019: 8 · 2018: 16 · 2017: 20 · 2016: 17 · 2015: 10 · 2014: 9
FWCI
7.66
Type
journal article
Language
en
Open access
Locations
  • Neurobiology of Aging (publishedVersion)
  • PubMed (publishedVersion)
  • Research Publications (Maastricht University) (publishedVersion, other-oa)
  • PubMed Central (acceptedVersion)
  • Open Access at Essex (University of Essex) (acceptedVersion)
  • Figshare (submittedVersion)
  • Research Portal (King's College London) (submittedVersion)
  • Open Research Exeter (University of Exeter) (submittedVersion, cc-by-nc-nd)
  • Research Publications (Maastricht University) (submittedVersion)
Funders
a US National Institutes of Health (NIH) (AG036039)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords
5-hydroxymethylcytosine, 5-formylcytosine, 5-carboxylcytosine, DNA methylation, demethylation, epigenetics, Alzheimer's disease, brain regions, entorhinal cortex, cerebellum
MeSH terms
Aged, Aged, 80 and over, Alzheimer Disease, Brain, Cytosine, Female, Fluorescent Antibody Technique, Humans, Ivermectin, Male, Methylation, Epigenesis, Genetic, 5-Methylcytosine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review